Table 2.
Comparison of single high-risk HPV infection type between the two groups (n, %)
| HR-HPV infection type | LSIL-CIN 1 group(n = 125) | HSIL-CIN 2, CIN 3 group(n = 115) | X2 | P |
|---|---|---|---|---|
| HR-HPV16 | 38(25.3) | 71(45.5) | 13.579 | 0.000 |
| h-HPV18 | 13(8.7) | 9(5.8) | 0.962 | 0.327 |
| h-HPV31 | 4(2.7) | 5(3.2) | 0.078 | 0.780 |
| h-HPV33 | 5(3.3) | 20(12.8) | 9.174 | 0.002 |
| h-HPV35 | 6(4.0) | 4(2.6) | 0.284 | 0.594 |
| h-HPV39 | 4(2.7) | 3(1.9) | 0.189 | 0.664 |
| h-HPV45 | 2(1.3) | 0(0.0) | 0.544 | 0.461 |
| h-HPV51 | 7(4.7) | 7(4.5) | 0.006 | 0.940 |
| h-HPV52 | 31(20.7) | 17(10.9) | 5.518 | 0.019 |
| h-HPV56 | 7(4.7) | 4(2.6) | 0.708 | 0.400 |
| h-HPV58 | 21(14.0) | 10(6.4) | 4.838 | 0.028 |
| h-HPV59 | 4(2.7) | 2(1.3) | 0.157 | 0.692 |
| h-HPV66 | 1(0.6) | 0(0.0) | 0.000 | 0.989 |
| h-HPV68 | 7(4.7) | 4(2.6) | 0.523 | 0.469 |
| Total | 150(100) | 156(100) |
Note: LSIL: Low-grade cervical intraepithelial lesion; HR-HPV : high-risk human papillomavirus; HSIL: High-grade cervical intraepithelial lesion; CIN: cervical intra-epithelial neoplasia